VALIANT® Captivia VAMC4646C200TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMC4646C200TU VALCAP CLOSE · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169346437), received between Sep 19, 2017 and Oct 26, 2018 — classified as 1 death, 2 injuries.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Leak/Splash1
Patient problems
- Death1
- Injury1
- Loss Of Pulse1
- Perforation of Vessels1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryOct 26, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 80MM DIAMETER THORACIC AORTIC ANEURYSM. IT WAS REPORTED THAT DURING THE INDEX PROCEDURE (POST SUCCESSFUL DELIVERY OF THE STENT GRAFTS) WHEN THE SHEATH WAS BEING REMOVED THE ILIAC ARTERY RUPTURED. AN OPEN PROCEDURE WAS PERFORMED TO REPAIR THE RUPTURED ILIAC ARTERY. PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS DUE TO PATIENT ANATOMY; SMALL ILIAC ACCESS. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Perforation of Vessels
MAUDE report 8008278 ↗DeathJul 11, 2018Adverse Event Without Identified Device or Use Problem
A VALIANT THORACIC STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT ON A 63MM DIAMETER THORACIC AORTIC ANEURYSM. DURING THE INDEX PROCEDURE IT WAS REPORTED THAT AS THE DEVICE WAS BEING ADVANCED THE PATIENTS ARTERIAL PRESSURE DROPPED AND THERE WAS A LOSS OF HEART RHYTHM. THE PROCEDURE WAS CONVERTED TO AN OPEN REPAIR AND IT WAS NOTED THAT THERE WAS A TEAR PRESENT IN THE AORTA DISTAL TO THE LEFT SUBCLAVIAN ARTERY. THE STENT GRAFT WAS PASSED ACROSS THE TEAR AND DEPLOYED. A DISTAL EXTENSION WAS ALSO THEN DEPLOYED. IT WAS REPORTED THAT THE PATIENT EXPIRED. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS ANATOMY RELATED DUE TO THE PATIENT HAVING A TYPE 3 AORTIC ARCH. THE PHYSICIAN ADDITIONALLY NOTED THAT NO OVERT AGGRESSIVE PRESSURE WAS EXERTED. IT WAS ALSO NOTED THAT ON OPENING THE CHEST THE AORTA FELT VERY THIN. NO ADDITIONAL CLINICAL SEQUALAE WERE REPORTED.
Patient problems: Death; Loss Of Pulse
MAUDE report 7676817 ↗InjurySep 19, 2017Leak/Splash; Leak/Splash
A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED THAT THE PATIENT PRESENTED FOR FOLLOW UP ON AN UNKNOWN DATE. A RECENT CT REVEALED A TYPE III SEPARATION ENDOLEAK BETWEEN TWO VALIANT STENT GRAFTS. THE PHYSICIAN ELECTED TO IMPLANT ANOTHER VALIANT STENT GRAFT AND THE TYPE III SEPARATION ENDOLEAK WAS RESOLVED. PER THE PHYSICIAN, THE CAUSE OF THE TYPE III SEPARATION ENDOLEAK WAS DUE TO THE PATIENT¿S ANATOMY REMODELING. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Injury
MAUDE report 6875657 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page